ArticleGut2021

Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.

Peter Georgeson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.